Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

Who is best to test? A systematic review of chlamydia infections in Switzerland
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
ID 4652501
Author(s) Haag, M.; Zemp, E.; Hersberger, K. E.; Arnet, I.
Author(s) at UniBasel Zemp Stutz, Elisabeth
Hersberger, Kurt
Arnet, Isabelle
Haag, Melanie
Year 2020
Title Who is best to test? A systematic review of chlamydia infections in Switzerland
Journal International Journal of Environmental Research and Public Health
Volume 17
Number 24
Pages / Article-Number 9389
Keywords chlamydia; screening; pharmacy; Switzerland
Mesh terms Adult; Chlamydia Infections, epidemiology; Cohort Studies; Cross-Sectional Studies; Female; HIV Infections; Homosexuality, Male; Humans; Male; Pregnancy; Sexual and Gender Minorities; Sexually Transmitted Diseases; Switzerland, epidemiology
Abstract In many countries, community pharmacies provide sexual-health-related services to limit the spread of sexually transmitted infections (STIs), including chlamydia testing. To identify suitable target groups for pharmacy-based chlamydia testing in Switzerland, we aimed to assess chlamydia prevalence, identify risk groups, and delineate screening strategies. We conducted a systematic literature search up to December 2019 in PubMed, EMBASE, and Web of Science, according to the PRISMA guidelines, using as keywords "chlamydia", "screening", and "Switzerland". Two researchers screened the title, abstract, and full-text article and assessed the methodological quality. The literature search generated 108 hits, and nine studies were included. Chlamydia prevalence ranged between 0.8 and 12.8%. Most frequently affected were undocumented women undergoing voluntary termination of pregnancy (12.8%, 95% CI: 8.4-18.9), HIV-positive men who have sex with men (10.9%, 95% CI: 9.2-17.6), and adult offenders (6.5%, 95% CI: 3.2-9.0). Systematic screening was suggested for the first two risk groups and women suffering a miscarriage. To conclude, chlamydia infections are prevalent in Switzerland, but the identified risk groups are difficult to reach for a pharmacy-based testing service. More studies are needed to identify suitable target groups, including customers seeking sexual health services, particularly emergency contraception users who already receive counselling for STIs at community pharmacies.
Publisher MDPI
ISSN/ISBN 1661-7827 ; 1660-4601
Full Text on edoc Available
Digital Object Identifier DOI 10.3390/ijerph17249389
PubMed ID
ISI-Number WOS:000602939200001
Document type (ISI) Journal Article

MCSS v5.8 PRO. 0.350 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |